ArticleScientific reports2025
Antioxidant and neuroprotective effects of nutriosomes and grape pomace phytochemicals in a cell model of oxidative stress and mouse model of Parkinson disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- ExploitingAntioxidants (Basel, Switzerland) · 2026Article
- Synergistic Integration of Liposomes with Emerging Technologies for Food Applications.Molecules (Basel, Switzerland) · 2026Review
- ExploringAnimals : an open access journal from MDPI · 2025Article
- Sustainable Supramolecular Extraction of Phytocomplexes from Microgreens and Their Eco-Loading in Nutriosomes: Physicochemical Characterization, Stability, and In Vitro Release Behavior.Molecules (Basel, Switzerland) · 2025Article
- Physicochemical Characteristics of Phospholipid Vesicles for Spirulina-Based Dietary Supplement Delivery.Molecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of the present study was to evaluate the effectiveness of a Cannonau pomace extract loaded in nutriosomes in intestinal oxidative stress and a subacute model of Parkinson disease and compare the results with those previously obtained with a Nasco pomace extract loaded in the same nutriosomes. In this study, Cannonau pomace was extracted using ultrasound-assisted maceration to obtain a polyphenol-rich extract. The extract at two different concentrations (5 and 10 mg/mL) was loaded in the same nutriosomes previously used to deliver Nasco pomace extract were loaded in nutriosomes. The main physico-chemical and technological characteristics of the obtained vesicles, along with their stability over time were measured. The in vitro biocompatibility and ability of nutriosomes to protect intestinal epithelial cells (Caco-2) from oxidative damages, were evaluated. Finally, the effectiveness of repeated administration of Cannonau extract in dispersion or loaded in nutriosomes against the neurotoxic effects in mice was evaluated. The resulting vesicles had uniform distribution, controlled the release of payloads, were biocompatible, like nutriosomes loading Nasco pomace extract, protected the intestinal cells against damages induced by hydrogen peroxide, in a better extent than the Nasco nutriosomes. However, no significant neuroprotective effects were observed in in vivo experiments performed using a subacute model of Parkinson disease, unlike previous results obtained with Nasco pomace extract loaded nutriosomes. This discrepancy is possibly due to the absence of key polyphenols like procyanidin B2 in the Cannonau extract, which are instead present in the Nasco extract. The findings suggest that while nutriosomes enhance the bioavailability and efficacy of grape pomace extracts in vitro, their therapeutic potential in vivo may depend on the specific phenolic profile of the extract used. Further research is needed to optimize formulations and explore synergistic combinations for improved neuroprotective outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.